Paula Marynella Alves Pereira Lima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Paula Marynella Alves Pereira Lima has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Ana Carolina Nakao e Borges
Centro Universitário de Patos de Minas
1 shared publication - Ana Carolina Seni-Silva
Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto 14049-900, SP, Brazil
1 shared publication Claudio Vieira da Silva
Department of Immunology, Biomedical Sciences Institute, Federal University of Uberlândia, MG, Brazil
1 shared publication- Fernanda Van Petten de Vasconcelos Azevedo
Laboratory of Biochemistry and Animal Toxins, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia 38408-100, MG, Brazil
1 shared publication - Isabelly Cristina Pereira da Silva
Centro Universitário de Patos de Minas
1 shared publication - Isadora Bernardes de Melo1 shared publication
Latest Publications
- Open Access
- 1 December 2025
- Published by Research, Society and Development in Research, Society and Development
- Vol. 14 (12)
Incidência de câncer de mama em Uberlândia, Uberaba e Araguari de 2020 a 2023
Introdução: O câncer de mama é a principal causa de morte por câncer entre mulheres no Brasil. O diagnóstico precoce, por meio da mamografia, é essencial para aumentar as chances de cura. O objetivo desse estudo foi analisar os dados referentes à mamografia e exames histopatológicos em municípios do Triângulo Mineiro, como Araguari, Uberaba e Uberlândia, nos anos de 2020 a 2023. Metodologia: A pesquisa é quantitativa e descritiva, utilizando dados do SISCAN e DATASUS sobre a realização de mamografias e exames histopatológicos nas cidades de Araguari, Uberlândia e Uberaba, nos anos de 2020 a 2023. Resultados e Discussão: Os resultados mostram uma maior cobertura de rastreamento em Uberlândia e consequente menor mortalidade, com queda na realização de exames durante a pandemia. A pandemia impactou negativamente o rastreamento, mas a retomada do processo em 2023 melhorou os índices. A análise histopatológica revelou predomínio de carcinoma ductal invasivo. Conclusão: A pesquisa evidencia a importância do diagnóstico precoce e do acesso à mamografia, principalmente em desfechos como mortalidade. A desigualdade no acesso à saúde destaca a necessidade de políticas públicas mais eficazes para reduzir a mortalidade por câncer de mama, especialmente em áreas com menor cobertura dos serviços.
- 1 December 2025
- Published by Research, Society and Development in Research, Society and Development
- Vol. 14 (12)
Open AccessIncidência de câncer de mama em Uberlândia, Uberaba e Araguari de 2020 a 2023
Introdução: O câncer de mama é a principal causa de morte por câncer entre mulheres no Brasil. O diagnóstico precoce, por meio da mamografia, é essencial para aumentar as chances de cura. O objetivo desse estudo foi analisar os dados referentes à mamografia e exames histopatológicos em municípios do Triângulo Mineiro, como Araguari, Uberaba e Uberlândia, nos anos de 2020 a 2023. Metodologia: A pesquisa é quantitativa e descritiva, utilizando dados do SISCAN e DATASUS sobre a realização de mamografias e exames histopatológicos nas cidades de Araguari, Uberlândia e Uberaba, nos anos de 2020 a 2023. Resultados e Discussão: Os resultados mostram uma maior cobertura de rastreamento em Uberlândia e consequente menor mortalidade, com queda na realização de exames durante a pandemia. A pandemia impactou negativamente o rastreamento, mas a retomada do processo em 2023 melhorou os índices. A análise histopatológica revelou predomínio de carcinoma ductal invasivo. Conclusão: A pesquisa evidencia a importância do diagnóstico precoce e do acesso à mamografia, principalmente em desfechos como mortalidade. A desigualdade no acesso à saúde destaca a necessidade de políticas públicas mais eficazes para reduzir a mortalidade por câncer de mama, especialmente em áreas com menor cobertura dos serviços.
- Open Access
- 13 January 2023
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (2)
Aspectos clínicos, diagnóstico diferencial e tratamento de jovens com Transtorno do Déficit de Atenção com Hiperatividade (TDAH)
Introduction: The Attention Deficit Hyperactivity Disorder (ADHD) is a neurological condition that impairs focus or attention, it is a pathology frequently diagnosed in childhood, however, it is not identified until adolescence. Generally, there is a genetic component in the pathophysiology of ADHD, however, there are other causes that are not yet well established. Objective: To analyze clinical aspects and the treatment indicated for young people diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Methodology: This is a narrative review of the literature, with articles selected from the databases: National Library of Medicine (PubMed MEDLINE), EbscoHost, Google Scholar, Scientific Eletronic Library Online (SCIELO) and Virtual Health Library (BVS) Results: According to the review conducted, it was found that ADHD is composed of two groups of symptoms: inattention and hyperactivity-impulsivity. In addition, inattention and impulsivity problems are characteristics that parents often ignore, contributing to a late diagnosis. Furthermore, adolescents and adults have less hyperactivity than children; however, there is a significant deficit in executive functions, which may compromise their intellectual development. Conclusion: We can state that ADHD symptoms vary according to gender, age, and type of Attention Deficit Hyperactivity Disorder. Therefore, a prior diagnosis is of utmost importance for the young ADHD sufferer to have a good quality of life, as provided by the World Health Organization.
- 13 January 2023
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (2)
Open AccessAspectos clínicos, diagnóstico diferencial e tratamento de jovens com Transtorno do Déficit de Atenção com Hiperatividade (TDAH)
Introduction: The Attention Deficit Hyperactivity Disorder (ADHD) is a neurological condition that impairs focus or attention, it is a pathology frequently diagnosed in childhood, however, it is not identified until adolescence. Generally, there is a genetic component in the pathophysiology of ADHD, however, there are other causes that are not yet well established. Objective: To analyze clinical aspects and the treatment indicated for young people diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Methodology: This is a narrative review of the literature, with articles selected from the databases: National Library of Medicine (PubMed MEDLINE), EbscoHost, Google Scholar, Scientific Eletronic Library Online (SCIELO) and Virtual Health Library (BVS) Results: According to the review conducted, it was found that ADHD is composed of two groups of symptoms: inattention and hyperactivity-impulsivity. In addition, inattention and impulsivity problems are characteristics that parents often ignore, contributing to a late diagnosis. Furthermore, adolescents and adults have less hyperactivity than children; however, there is a significant deficit in executive functions, which may compromise their intellectual development. Conclusion: We can state that ADHD symptoms vary according to gender, age, and type of Attention Deficit Hyperactivity Disorder. Therefore, a prior diagnosis is of utmost importance for the young ADHD sufferer to have a good quality of life, as provided by the World Health Organization.
- Open Access
- 18 December 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (17)
Rastreio de câncer de mama em transgêneros: uma revisão integrativa de literatura
Introduction: Breast cancer, with the exception of non-melanoma skin cancer, is the most frequent in Brazil. Breast cancer is stratified into subtypes according to its genesis. Estrogen, in turn, is a steroid hormone that is related to the origin of hormone-dependent breast cancer. In this context, hormone therapy, used in the treatment of menopausal symptoms and also in hormone therapy for transgenders, is directly involved with the volume of estrogen circulating in the body of these groups. Objective: Given the above, there is concern about the increased incidence of breast cancer in transgenders. Therefore, this literature review aimed to evaluate the relationship between breast cancer and hormone therapy in the long term, and also, the status of breast cancer screening in women and transgender men, as well as its challenges. Methodology: Literary review, resulting from searches in VHL, PubMed, EbscoHost and SciELO covering articles in English, Portuguese and Spanish. Results: Twelve articles were analyzed. It was evidenced in the literature insufficient documentation for a possible affirmation or denial of the relationship between hormone therapy and higher incidence of breast cancer in transgenders, due to the lack of studies. Conclusion: It is necessary that the epidemiology be better understood, so that there is some proper guideline regarding secondary prevention in transgender people, in addition to better preparation of professionals for quality care. Still, it is suggested that this population be better documented, in order to have more studies and specific policies.
- 18 December 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (17)
Open AccessRastreio de câncer de mama em transgêneros: uma revisão integrativa de literatura
Introduction: Breast cancer, with the exception of non-melanoma skin cancer, is the most frequent in Brazil. Breast cancer is stratified into subtypes according to its genesis. Estrogen, in turn, is a steroid hormone that is related to the origin of hormone-dependent breast cancer. In this context, hormone therapy, used in the treatment of menopausal symptoms and also in hormone therapy for transgenders, is directly involved with the volume of estrogen circulating in the body of these groups. Objective: Given the above, there is concern about the increased incidence of breast cancer in transgenders. Therefore, this literature review aimed to evaluate the relationship between breast cancer and hormone therapy in the long term, and also, the status of breast cancer screening in women and transgender men, as well as its challenges. Methodology: Literary review, resulting from searches in VHL, PubMed, EbscoHost and SciELO covering articles in English, Portuguese and Spanish. Results: Twelve articles were analyzed. It was evidenced in the literature insufficient documentation for a possible affirmation or denial of the relationship between hormone therapy and higher incidence of breast cancer in transgenders, due to the lack of studies. Conclusion: It is necessary that the epidemiology be better understood, so that there is some proper guideline regarding secondary prevention in transgender people, in addition to better preparation of professionals for quality care. Still, it is suggested that this population be better documented, in order to have more studies and specific policies.
- Open Access
- 1 April 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 112, 108586
Action of copper(II) complex with β-diketone and 1,10-phenanthroline (CBP-01) on sarcoma cells and biological effects under cell death
- 1 April 2019
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 112, 108586
Open AccessAction of copper(II) complex with β-diketone and 1,10-phenanthroline (CBP-01) on sarcoma cells and biological effects under cell death